Yili Financial Statements From 2010 to 2025
| 301301 Stock | 12.84 0.20 1.53% |
Gross Profit 2 B | Profit Margin | Market Capitalization 28.7 B | Enterprise Value Revenue 5.318 | Revenue |
Check Yili Chuanning financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Yili Chuanning's main balance sheet or income statement drivers, such as , as well as many indicators such as . Yili financial statements analysis is a perfect complement when working with Yili Chuanning Valuation or Volatility modules.
Yili |
Yili Chuanning Biotechnology Company Current Valuation Analysis
Yili Chuanning's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Yili Chuanning Current Valuation | 30.3 B |
Most of Yili Chuanning's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Yili Chuanning Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Yili Chuanning Biotechnology has a Current Valuation of 30.3 B. This is 110.98% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is 82.28% lower than that of the firm.
Yili Chuanning Biote Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Yili Chuanning's current stock value. Our valuation model uses many indicators to compare Yili Chuanning value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Yili Chuanning competition to find correlations between indicators driving Yili Chuanning's intrinsic value. More Info.Yili Chuanning Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Yili Chuanning Biotechnology is roughly 1.90 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Yili Chuanning by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Yili Chuanning's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Yili Chuanning Financial Statements
Yili Chuanning stakeholders use historical fundamental indicators, such as Yili Chuanning's revenue or net income, to determine how well the company is positioned to perform in the future. Although Yili Chuanning investors may analyze each financial statement separately, they are all interrelated. For example, changes in Yili Chuanning's assets and liabilities are reflected in the revenues and expenses on Yili Chuanning's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Yili Chuanning Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
Yili Chuanning is entity of China. It is traded as Stock on SHE exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Yili Stock
Yili Chuanning financial ratios help investors to determine whether Yili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yili with respect to the benefits of owning Yili Chuanning security.